Case Report Pneumology Dr. David Tran A&E, FVHospital Medical meeting September 28 th, 2011.

Slides:



Advertisements
Similar presentations
Venous Thrombo-embolism In Pregnancy
Advertisements

Venous thromboembolic diseases: Pulmonary embolism
Case report 30/09/09 Dr. David Tran A&E departement FVHospital.
Controversies in the management of Pulmonary Embolism
Bilateral Lower Extremity Pain
Brian M. Johnson, MD CCRMC PBL 11/7/12
VTE Toolkit Chapter Five Venous Disease Coalition
Deep venous thrombosis and pulmonary embolism in pregnancy Petr Krepelka, 2013.
P ULMONARY THROMBOEMBOLISM SPECIFIC SITUATIONS Dr.E.Shabani.
Treatment of Acute Pulmonary Embolism
VTE in abdominal-pelvic surgery patients
Bleeding and Thrombosis in Children Alice J. Cohen, M.D. Newark Beth Israel Medical Center.
Venous Thromboembolism
RecommendationsRecommendations Risk Recommendation Ambulation (all pts) IPC/GCS or, UFH 5000 SQ q 12 hrs or, Enoxaparin 40mg SQ daily IPC/GCS or, UFH 5000.
Deep vein thrombosis David Hughes. Pathophysiology normal deep pelvic/leg veins thrombus (red cells, fibrin) around valves propagation Virchow’s triad.
CHEST-2012: High Points and Pearls Alan Brush, MD, FACP Chief, Anticoagulation Management Service Harvard Vanguard Medical Associates.
DPT 732 SPRING 2009 S. SCHERER Deep Vein Thrombosis.
D-dimer in the Diagnosis of Pulmonary Embolism Cheryl Pollock PGY-3.
PROGRESS NOTE (SOAP Notes)
LIFEBLOOD THE Thrombosis CHARITY Venous thromboembolism – Treatment and secondary prevention Ulcus cruris Chronic PE PE DVT Post-thrombotic syndrome Death.
Unprovoked DVT in a young patient
Volume 359: November 6, 2008 Number 19November 6, 2008.
DVT: Symptoms and work-up Sean Stoneking. DVT Epidemilogy Approximately 600,0000 new cases of DVT each year 50% in hospitalized patients or nursing home.
Pulmonary Embolism. Definition: Sudden lodgment of a blood clot in a pulmonary artery with subsequent obstruction of blood supply to the lung parenchyma.
British Guideline on the Management of Asthma. Aims Review of current SIGN/BTS guidelines –Diagnosing Asthma –Stepwise management of Asthma –Managing.
Epidemiology and diagnosis of acute pulmonary embolism Dr Sam Z Goldhaber Associate Professor of Medicine Harvard Medical School Staff Cardiologist Brigham.
Pulmonary Embolism (PE)
DR FAROOQ AHMAD RANA ASSISTANT PROFESSOR SURGERY
What You Need to Know about Blood Clots. What You Need to Know About Blood Clots or Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)
PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM
By Dr. Zahoor 1. 2 A 65 year old woman is brought to the emergency room after coughing up several table spoons of bright red blood. For the last 3-4.
Pulmonary Embolism and Infarction
PBL CASE PRESENTATION. Presenting Complaint 70yo female Presents to ED with sudden onset SOB, chest pain and haemoptysis. Unable to walk due to recent.
Venous Thromboembolism
به نام خدا. دكتر محمد امامي فوق تخصص ريه عضو هيات علمي دانشگاه.
Shortness of breath By: Tina Tarazi. Patient is a 49 year old F with PMH of NSCLC s/p chemotherapy and radiation and right frontal lobe resection in 12/2013.
Venous Thromboembolism: Diagnosis and Managament
CARDIOVASCULAR MODULE: DEEP VENOUS THROMBOSIS THROMBOPHLEBITIS Adult Medical-Surgical Nursing.
Pulmonary Embolism. Introduction  Pulmonary Embolism is a complication of underlying venous thrombosis, most commonly of lower extremities and rarely.
APPROACH TO CHEST PAIN. OBJECTIVES  1. Establish a differential diagnosis for chest pain  2. Know what clues to obtain on history to rule-in or out.
Dr. Meg-angela Christi Amores
PULMONARY EMBOLI Kenney Weinmeister M.D.. PULMONARY EMBOLI w Over 500,000 cases per year. w Results in 200,000 deaths. w Mortality without treatment is.
71-year old male Admitted with worsening shortness of breath PMHx: Severe COPD, A.Fib, CHF/ischemic, PE On long term anticoagulation with Pradaxa 150.
Pulmonary Embolism Pulmonary embolism is blockage in one or more arteries in your lungs. Maggie Trainor.
DVT & PE: How early can I mobilize a patient ??
Peri-Operative anticoagulation /antiplatelet therapy A Shift in Paradigm BMHGT04/29/09.
 Deep Vein Thrombosis Josh Vrona, Hunter Dolan, Erin McCann.
Prof. Mona Mansour Professor of Pulmonary Medicine Ain Shams University.
Drugs Susan Louw Haematology Registrar. 4 Questions to ask: Can I stop? (What is the risk of thrombosis?) Should I stop? (What is the risk of bleeding?)
Managing suspected pulmonary embolism in primary care Referral for all? G.J. Geersing, M.D. PhD. Julius Center for Health Sciences and Primary Care EPCCS.
ACUTE ABDOMINAL PAIN Dr Ha Thi Hanh A&E. CASE REPORT Mr GRAS PAUL EUGENE 59 YO Mr GRAS PAUL EUGENE 59 YO VISIT DATE 15-DEC :10 VISIT DATE 15-DEC-2009.
DVT cases.  Heparin, low molecular weight heparin, or fondaparinux are usually continued for at least five days, along with another medication called.
PULMONARY EMBOLISM BY Dr. Hayam Hebah Associate professor of internal medicine AL-Maarefa College.
Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing June 2012 NICE clinical guideline.
Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing June 2012 NICE clinical guideline.
Antithrombotic Therapy for VTE: CHEST Guidelines 2016
Pulmonary Embolism Dr. Gerrard Uy.
One of the main causes of DVT is inactivity! When a person is inactive, your blood normally collects in the lower part of your body. (in your legs) This.
Venous Thromboembolic Disease: The Role of Novel Anticoagulants Grant M. Greenberg MD, MA, MHSA.
Asad Mehdi, MD. Outline A Diagnostic Approach to Pulmonary Embolism Clinical Presentation Risk Stratification Wells Criteria Geneva Rule PIOPED Approach.
Outpatient DVT assessment & treatment Daniel Gilada.
Diagnosis Recitation. The Dilemma At the conclusion of my “diagnosis” presentation during the recent IAPA meeting, a gentleman from the audience asked.
Deep Vein Thrombosis & Pulmonary Embolism
By: Dr. Nalaka Gunawansa
HKCEM JCM OSCE Friday 8 December 2017 TKOH.
By Dr Waqar MBBS, MRCP ASST. PROFESSOR PULMONARY EMBOLISM By Dr Waqar MBBS, MRCP ASST. PROFESSOR.
A Case Challenge: Anticoagulant Choices for Acute PE
Venous Thromboembolism (VTE)
Calculate Well’s score for PE (BOX1)
Treatment algorithm. Treatment algorithm. (A) Suggested treatment algorithm for symptomatic and incidental DVT or PE in cancer patients. (B) Suggested.
Presentation transcript:

Case Report Pneumology Dr. David Tran A&E, FVHospital Medical meeting September 28 th, 2011

Female 26 years old Consults A&E on September 18 th for chest pain, cough with small amount of blood in the sputum during the night. Consults A&E on September 18 th for chest pain, cough with small amount of blood in the sputum during the night. Complains about shortness of breath for 2 or 3 days. Complains about shortness of breath for 2 or 3 days. She mentions a traffic accident 3 weeks ago without thoracic trauma (just a small trauma at the R knee) She mentions a traffic accident 3 weeks ago without thoracic trauma (just a small trauma at the R knee) She has been in close contact with a acute case of tuberculosis a few months ago. She has been in close contact with a acute case of tuberculosis a few months ago. No past medical history, she smokes 20 cig./day. No past medical history, she smokes 20 cig./day.

Physical examination Pulse 58/min, BP 100/60, RR 18/min., SpO2 100% (air), EVA 4/10, Glasgow 15. Pulse 58/min, BP 100/60, RR 18/min., SpO2 100% (air), EVA 4/10, Glasgow 15. Auscultation shows slight decreased mumure in the right base of the thorax, no rales, no crackles. Auscultation shows slight decreased mumure in the right base of the thorax, no rales, no crackles. There is no sign of chest trauma, the ribs are not painful at palpation, the abdomen is soft. There is no sign of chest trauma, the ribs are not painful at palpation, the abdomen is soft. The legs are not swollen, there is a splint on the right knee no pain at the right calf, no Homans sign. The legs are not swollen, there is a splint on the right knee no pain at the right calf, no Homans sign.

ECG

Chest Xray

Hematological results

Biochemical results

D. Dimeres results

After discussion with the patient She informed us that she had bed rest for almost 3 weeks after her accident due to the immobilization of the right leg in a splint. She informed us that she had bed rest for almost 3 weeks after her accident due to the immobilization of the right leg in a splint. She received no anticoagulation during this time. She received no anticoagulation during this time. She has no personnal or familial history of thrombosis. She has no personnal or familial history of thrombosis. S he uses to smoke about 20 cig./day and takes oral contraceptive pils for 2 years. S he uses to smoke about 20 cig./day and takes oral contraceptive pils for 2 years.

Angio CT scanner thorax

AngioCT scanner of the thorax

Treatment Perfalgan 1g + Morphin 3mg (scanner) Perfalgan 1g + Morphin 3mg (scanner) Lovenox 0.6ml (60mg) s/cut x 2 per day Lovenox 0.6ml (60mg) s/cut x 2 per day Start Coumadine 4mg the day after Start Coumadine 4mg the day after Check INR 48h to 72h after the onset of anti-vitK treatment. Check INR 48h to 72h after the onset of anti-vitK treatment. Contention socks Contention socks Hospitalized in medical ward (Dr Thai, cardiologist) Hospitalized in medical ward (Dr Thai, cardiologist)

DVT & Pulmonary Embolism 117 cases / persons in USA (increases with the age) 117 cases / persons in USA (increases with the age) Importance of risk factors (immobilization, contraceptive drugs, flight travel, familial or personal past history) Importance of risk factors (immobilization, contraceptive drugs, flight travel, familial or personal past history) Most clinical PE originate from a proximal DVT from the legs above the knee (popliteal, femoral or iliac vein) Most clinical PE originate from a proximal DVT from the legs above the knee (popliteal, femoral or iliac vein) As many patients have intermediate probability of venous thrombosis, clinical jugement is still the cornerstone of the diagnosis. As many patients have intermediate probability of venous thrombosis, clinical jugement is still the cornerstone of the diagnosis.

Risk factors

D-Dimer tests D-Dimer are very sensitive but have a very low specificity (Good negative predictive value) D-Dimer are very sensitive but have a very low specificity (Good negative predictive value) D-Dimer can rule out the diagnosis of PE in only 5% of patients aged > 80 years (60% in young patients 80 years (60% in young patients < 40 years old) Low risk of DVT assessment by validated prediction score and a negative D-dimer test (Latex agglutination) is deemed to rule out the diagnosis of DVT. Low risk of DVT assessment by validated prediction score and a negative D-dimer test (Latex agglutination) is deemed to rule out the diagnosis of DVT. D-Dimer positive result does not raise the likelihood of DVT and has therefore limited clinical value alone. D-Dimer positive result does not raise the likelihood of DVT and has therefore limited clinical value alone.

Clinical probability score (Geneve Score)

Wells score of probability for PE

Assess clinical probability

Use of d-dimer and angio-CT for the diagnosis of Pulmonary Embolism

Decisional algorithm for the diagnosis of PE

CT pulmonary angiography (Se 83%, Sp 96%)

Principle of PE treatment Immediate full anticoagulation is mandatory for all patients suspected of having have DVT or pulmonary embolism. Immediate full anticoagulation is mandatory for all patients suspected of having have DVT or pulmonary embolism. Diagnostic investigations should not delay empirical anticoagulant therapy. Diagnostic investigations should not delay empirical anticoagulant therapy. Current guidelines recommend starting unfractionated heparin (UFH), low–molecular weight heparin (LMWH), or fondaparinux (all grade 1A) in addition to an oral anticoagulant (warfarin) at the time of diagnosis Current guidelines recommend starting unfractionated heparin (UFH), low–molecular weight heparin (LMWH), or fondaparinux (all grade 1A) in addition to an oral anticoagulant (warfarin) at the time of diagnosis Discontinue UFH, LMWH only after the international normalized ratio (INR) is 2.0 for at least 24 hours, but no sooner than 5 days after warfarin therapy has been started (grade 1C recommendation). Discontinue UFH, LMWH only after the international normalized ratio (INR) is 2.0 for at least 24 hours, but no sooner than 5 days after warfarin therapy has been started (grade 1C recommendation).

Curative Treatment Low molecular weight heparin (LMWH) Low molecular weight heparin (LMWH) LOVENOX 0.1ml/10Kg sub-cut twice a day LOVENOX 0.1ml/10Kg sub-cut twice a day Early relay with anti-vitamin K by mouth Early relay with anti-vitamin K by mouth INR after 48-72h of treatment INR after 48-72h of treatment Stop Heparin when INR 2< <4 at 2 times Stop Heparin when INR 2< <4 at 2 times Duration of efficient anticoagulation minimum 3 to 6 months (according persistent risk factors) Duration of efficient anticoagulation minimum 3 to 6 months (according persistent risk factors)

Think to Pulmonary Embolism!